A Nomogram Predicting the Response to Tocilizumab in Treating Active, Moderate-To-Severe, Glucocorticoid-Resistant Thyroid Eye Disease: A Multicenter Retrospective Study

Post time 1 hour(s) ago

journal：Seminars in Ophthalmology

Authors：Jingjing Yu; Fanrui Meng; Zhipeng Cui; Zhiwei He; Li Sun; Yi Wang; Hongwei Gao; Yu Li; Chao Wan; Aihua Liu; Yushu Li; Zhongyan Shan; Chao Liu; Shuhang Xu

Published date：--

DOI：10.1080/08820538.2026.2684996

PDF link：https://www.tandfonline.com/doi/pdf/10.1080/08820538.2026.2684996

Article link：https://doi.org/10.1080/08820538.2026.2684996

Article Source：Informa UK Limited。

Remark：

Post time Half hour(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Taylor&Francis] A Nomogram Predicting the Response to Tocilizumab in Treating Active, Moderate-To-Severe, Glucocorticoid-Resistant Thyroid Eye Disease: A Multicenter Retrospective Study

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Taylor&Francis] A Nomogram Predicting the Response to Tocilizumab in Treating Active, Moderate-To-Severe, Glucocorticoid-Resistant Thyroid Eye Disease: A Multicenter Retrospective Study Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Taylor&Francis] A Nomogram Predicting the Response to Tocilizumab in Treating Active, Moderate-To-Severe, Glucocorticoid-Resistant Thyroid Eye Disease: A Multicenter Retrospective Study